Showing results (31-40 of 100) with videos related to
Sort By:
Pageof 10
Cancer Chemotherapy and Pharmacology|April 27, 2002
The pharmacokinetics of the bispecific antibody MDX-H210 when combined with interferon gamma-1b in a multiple-dose phase I study in patients with advanced cancerLionel D Lewis, Andrew P Beelen, Bernard F Cole, et al.Clinical Breast Cancer|November 14, 2018
Phase 1b Study of Trebananib Plus Paclitaxel and Trastuzumab in Patients With HER2-Positive Locally Recurrent or Metastatic Breast CancerPeter A Kaufman, Hans Wildiers, Gilles Freyer, et al.BMC Cancer|June 3, 2014
The SystHERs registry: an observational cohort study of treatment patterns and outcomes in patients with human epidermal growth factor receptor 2-positive metastatic breast cancerDebu Tripathy, Hope S Rugo, Peter A Kaufman, et al.Breast Cancer Research and Treatment|August 9, 2012
Phase 1b dose-finding study of motesanib with docetaxel or paclitaxel in patients with metastatic breast cancerRichard H De Boer, Dusan Kotasek, Shane White, et al.JAMA Network Open|February 22, 2023
Cumulative 6-Year Risk of Screen-Detected Ductal Carcinoma In Situ by Screening FrequencyBrian L Sprague, Shuai Chen, Diana L Miglioretti, et al.IEEE Transactions on Medical Imaging|July 30, 2014
Real-time electrical impedance variations in women with and without breast cancerRyan J Halter, Alex Hartov, Steven P Poplack, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 15, 2010
Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserveTim A Ahles, Andrew J Saykin, Brenna C McDonald, et al.Breast Cancer Research : BCR|July 9, 2016
"New" metastases are associated with a poorer prognosis than growth of pre-existing metastases in patients with metastatic breast cancer treated with chemotherapyChristopher Twelves, Javier Cortes, Peter A Kaufman, et al.Nature Medicine|October 27, 2014
Microscopic lymph node tumor burden quantified by macroscopic dual-tracer molecular imagingKenneth M Tichauer, Kimberley S Samkoe, Jason R Gunn, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 9, 2014
Predicting breast tumor response to neoadjuvant chemotherapy with diffuse optical spectroscopic tomography prior to treatmentShudong Jiang, Brian W Pogue, Peter A Kaufman, et al.Pageof 10